Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension

Mise à jour : Il y a 4 ans
Référence : NCT01470144

Femme et Homme

Extrait

This is an open-label, nonrandomized extension to study AC-066A301. The study will assess safety and tolerability of ACT-385781A while providing a means for continuing treatment after ending participation in study AC-066A301.


Critère d'inclusion

  • pulmonary arterial hypertension


Liens